AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2026
Feb 12, 2026
32801_dirs_2026-02-12_9b4671b2-3b8b-4c56-aeed-224bb1abe9dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2026-02-10
Reporting Person: RODRIGUEZ RAUL R (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-10 | Common Stock | F | 7607 | $34.62 | Disposed | 228102 | Direct |
More from RIGEL PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19